BioSpace News Archive

Crinetics Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2020

Abbott (NYSE: ABT) announced today new research, published in the Journal of Clinical Microbiology, which found that its SARS-CoV-2 IgG lab-based serology blood test had 99.9% specificity and 100% sensitivity for detecting the IgG antibody in patients 17 days or more after symptoms began.

- Selected as a Poster of Distinction for presentation during Digestive Disease Week 2020 - Proved its efficacy with outstanding inhibition of gastric acid secretion and safety - Proactively targeting the anti-acid secretion agent market valued $37 billion

BioPharmX Corporation (NYSE American: BPMX) (“BioPharmX”) is urging its stockholders to vote now on the proposed merger of BioPharmX with Timber Pharmaceuticals LLC (“Timber”) and related matters as described in the proxy statement/prospectus.

Vuzix glasses are now being used by doctors in the Johns Hopkins Hospital ICU for training and conducting remote virtual patient rounds in response to COVID-19

The PA Clinical Network, Pennsylvania’s only health care provider-led clinically integrated network, announced today that Aetna, a CVS Health company and a leading provider of health insurance and related services, has initiated a value-based contract for Aetna’s Medicare Advantage members being cared for in the Network. Aetna offe

AMCP, the professional association leading the way to help patients get the medications they need at a cost they can afford, announced that it received two Hermes Creative Awards for its work to rebrand the organization in 2019.

Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, announced that the Company will release its 2020 first quarter financial results on Tuesday, May 12, 2020, after the close of the U.S. financial markets.

CENTOGENE, a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced that it will be providing its fully validated SARS-CoV-2-PCR tests to students from the Carolinum High School, the largest high school in Neustrelitz, Germany.

BIOREM Inc. announced its results for the three and twelve-month periods ended December 31, 2019.